Amgen (AMGN) Interest Expenses (2009 - 2026)

Amgen's Interest Expenses history runs 18 years deep, the most recent figure standing at $657.0 million for Q1 2026.

• In Q1 2026, Interest Expenses fell 9.13% year-over-year to $657.0 million; the TTM figure through Mar 2026 stood at $2.7 billion (down 11.95% YoY), while the FY2025 annual figure was $2.8 billion, down 12.68% from the prior year.
• Interest Expenses was $657.0 million for Q1 2026 at Amgen, up from $653.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $824.0 million in Q1 2024 to a low of $295.0 million in Q1 2022.
• Historically, Interest Expenses has averaged $638.1 million across 5 years, with a median of $694.0 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Interest Expenses jumped 129.27% in 2023, then declined 14.11% in 2025.
• A 5-year view of Interest Expenses shows it stood at $415.0 million in 2022, then jumped by 97.83% to $821.0 million in 2023, then fell by 9.01% to $747.0 million in 2024, then slipped by 12.58% to $653.0 million in 2025, then climbed by 0.61% to $657.0 million in 2026.
• The last three Interest Expenses figures came in at $657.0 million (Q1 2026), $653.0 million (Q4 2025), and $685.0 million (Q3 2025), per Business Quant data.